Suppr超能文献

MRI 分析载水凝胶阿帕替尼用于裸鼠肝癌模型的局部治疗。

MRI analysis of hydrogel-loaded apatinib for local therapy of hepatocellular carcinoma model in nude mice.

机构信息

Department of Radiology Zhongnan Hospital of Wuhan University, Wuhan, China.

Department of Medical Imaging, Ezhou Central Hospital, Ezhou, China.

出版信息

Biochem Biophys Res Commun. 2019 Feb 5;509(2):529-534. doi: 10.1016/j.bbrc.2018.12.120. Epub 2018 Dec 28.

Abstract

AIM

To investigate the effect of local treatment of gadolinium-polyethylene glycol (Gd-PEG) hydrogel containing apatinib injected into hepatocellular carcinoma model of HepG2 in nude mice, and to evaluate the MRI findings in vivo.

METHODS

HepG2 cells were treated in vitro and OD 450 value were measured. The four groups (n = 6) were Apatinib-Gd-PEG hydrogel, Gd-PEG hydrogel, Apatinib, and Saline. T1WI and DWI scans were performed before and 1d, 3d, and 14d postoperatively. The samples were examined by histomorphology and immunohistochemistry for CD34 and VEGFR2. Microvessel density (MVD) was evaluated and the average optical density (AOD) of VEGFR2 was obtained by IPP6.0 image software.

RESULTS

The OD450-time curves of Gd-PEG hydrogel and phosphate buffer saline (PBS) were similar and that of apatinib at all concentrations are located below; the higher the concentration, the lower the curve. On T1WI and DWI, the newly injected Gd-PEG hydrogel showed significant high signal and was immobilized in the tumor. Subsequently, the size and signal of Gd-PEG hydrogel gradually decreased with time. In Apatinib-Gd-PEG hydrogel group, compared with other three groups, MRI and histomorphology showed that the necrotic area of hepatocellular carcinoma model was larger, immunohistochemistry displayed minimal expression of CD34 and VEGFR2, the AOD of VEGFR2 and MVD differed markedly.

CONCLUSION

Gd-PEG hydrogel can significantly enhance and prolong the inhibitory effect of apatinib. It can be visualized by MRI, which can be used to evaluate the local therapeutic effect.

摘要

目的

研究向裸鼠 HepG2 肝癌模型中注射载阿帕替尼聚乙二醇(Gd-PEG)水凝胶的局部治疗效果,并评估体内 MRI 表现。

方法

体外处理 HepG2 细胞并测量 OD450 值。四组(每组 n=6)分别为:阿帕替尼-Gd-PEG 水凝胶组、Gd-PEG 水凝胶组、阿帕替尼组和生理盐水组。在术前及术后 1d、3d 和 14d 行 T1WI 和 DWI 扫描。通过组织形态学和 CD34、VEGFR2 免疫组化检查样本。采用 IPP6.0 图像软件评估微血管密度(MVD)并获取 VEGFR2 的平均光密度(AOD)。

结果

Gd-PEG 水凝胶和磷酸盐缓冲盐水(PBS)的 OD450-时间曲线相似,所有浓度的阿帕替尼均位于下方;浓度越高,曲线越低。在 T1WI 和 DWI 上,新注射的 Gd-PEG 水凝胶显示出明显的高信号,且固定在肿瘤内。随后,随着时间的推移,Gd-PEG 水凝胶的大小和信号逐渐降低。在阿帕替尼-Gd-PEG 水凝胶组中,与其他三组相比,MRI 和组织形态学显示肝癌模型的坏死区域更大,免疫组化显示 CD34 和 VEGFR2 的表达最小,VEGFR2 的 AOD 和 MVD 差异显著。

结论

Gd-PEG 水凝胶能显著增强并延长阿帕替尼的抑制作用。其可通过 MRI 可视化,可用于评估局部治疗效果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验